Tune in to Cherry Bekaert’s Q1 2026 R&D Tax Credit Update, where our knowledgeable team breaks down key opportunities, compliance considerations and recent developments impacting companies of all sizes.
We also cover the ongoing effects of IRC Section 174 — including required capitalization and amortization of foreign research expenditures — and provide practical insights into navigating both the Section 41 R&D Credit and Section 174A rules. Receive clear guidance on current challenges and upcoming IRS reporting requirements that may affect your business in 2026 and beyond.
What to Expect:
- Learn about the R&D tax credit, including eligibility requirements, qualifying activities and how the credit can benefit businesses across multiple industries.
- Discover considerations for addressing Section 174 capitalization that should have been reported in prior tax years.
- Determine the pros and cons of amending 2022 – 2024 tax returns for eligible small businesses that capitalized R&E in those years.
- Gain insights on states that do and do not conform to the new Section 174A.
- Receive practical guidance for identifying, documenting and substantiating qualified research expenses (QREs) to help maximize credit claims in light of the new Form 6765 requirements.
- Uncover industry-specific insights, including how companies in technology, manufacturing, life sciences and other sectors can leverage the R&D Tax Credit.
Related Insights
- Discover how our R&D Tax Credit Services professionals can help your organization maximize incentives and satisfy IRS filing requirements
- Learn more about the Section 174 Repeal and the pros and cons of amending vs. not amending 2022 – 2024 Tax Returns for R&E Deductions
- Explore the latest updates to Form 6765
